733
Views
16
CrossRef citations to date
0
Altmetric
Research Paper

PRKCZ-AS1 promotes the tumorigenesis of lung adenocarcinoma via sponging miR-766-5p to modulate MAPK1

, ORCID Icon &
Pages 364-371 | Received 26 Jun 2019, Accepted 01 Dec 2019, Published online: 15 Jan 2020

References

  • Ettinger DS, Akerley W, Bepler G, Blum MG, Chang A, Cheney RT, Chirieac LR, D’Amico TA, Demmy TL, Ganti AKP, et al. Non-small cell lung cancer. J National Compr Cancer Network. 2010;8:740–801. doi:10.6004/jnccn.2010.0056.
  • Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29. doi:10.3322/caac.21208.
  • Kabbout M, Garcia MM, Fujimoto J, Liu DD, Woods D, Chow CW, Mendoza G, Momin AA, James BP, Solis L, et al. ETS2 mediated tumor suppressive function and MET oncogene inhibition in human non-small cell lung cancer. Clin Cancer Res. 2013;19:3383–3395. doi:10.1158/1078-0432.CCR-13-0341.
  • Xu C, Xie D, Yu SC, Yang XJ, He LR, Yang J, Ping Y-F, Wang B, Yang L, Xu S-L, et al. Beta-Catenin/POU5F1/SOX2 transcription factor complex mediates IGF-I receptor signaling and predicts poor prognosis in lung adenocarcinoma. Cancer Res. 2013;73:3181–3189. doi:10.1158/0008-5472.CAN-12-4403.
  • Saji H, Tsuboi M, Shimada Y, Kato Y, Hamanaka W, Kudo Y, YOSHIDA K, MATSUBAYASHI J, USUDA J, OHIRA T, et al. Gene expression profiling and molecular pathway analysis for the identification of early-stage lung adenocarcinoma patients at risk for early recurrence. Oncol Rep. 2013;29:1902–1906. doi:10.3892/or.2013.2332.
  • Behera M, Owonikoko TK, Gal AA, Steuer CE, Kim S, Pillai RN, Khuri FR, Ramalingam SS, Sica GL. Lung adenocarcinoma staging using the 2011 IASLC/ATS/ERS classification: a pooled analysis of adenocarcinoma in situ and minimally invasive adenocarcinoma. Clin Lung Cancer. 2016;17:e57–e64. doi:10.1016/j.cllc.2016.03.009.
  • Borczuk AC. Prognostic considerations of the new World Health Organization classification of lung adenocarcinoma. European Respir Rev. 2016;25:364–371. doi:10.1183/16000617.0089-2016.
  • Li Z, Yamada S, Wu Y, Wang KY, Liu YP, Uramoto H, Kohno K, Sasaguri Y. Polypeptide N-acetylgalactosaminyltransferase-6 expression independently predicts poor overall survival in patients with lung adenocarcinoma after curative resection. Oncotarget. 2016;7:54463–54473. doi:10.18632/oncotarget.9810.
  • Zhou J, Xiao H, Yang X, Tian H, Xu Z, Zhong Y, Ma L, Zhang W, Qiao G, Liang J, et al. Long noncoding RNA CASC9.5 promotes the proliferation and metastasis of lung adenocarcinoma. Sci Rep. 2018;8:37. doi:10.1038/s41598-017-18280-3.
  • Zhang N, Jiang W. Long noncoding RNA DANCR promotes HMGA2mediated invasion in lung adenocarcinoma cells. Oncol Rep. 2019;41:1083–1090. doi:10.3892/or.2018.6897.
  • Liu L, Ni J, He X. Upregulation of the long noncoding RNA SNHG3 promotes lung adenocarcinoma proliferation. Dis Markers. 2018;2018:5736716. doi:10.1155/2018/5736716.
  • Su C, Shi K, Cheng X, Han Y, Li Y, Yu D, Liu Z. Long noncoding RNA LINC00472 inhibits proliferation and promotes apoptosis of lung adenocarcinoma cells via regulating miR-24-3p/DEDD. Technol Cancer Res Treat. 2018;17:1533033818790490. doi:10.1177/1533033818790490.
  • Acunzo M, Romano G, Wernicke D, Croce CM. MicroRNA and cancer–a brief overview. Adv Biol Regul. 2015;57:1–9. doi:10.1016/j.jbior.2014.09.013.
  • Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297. doi:10.1016/S0092-8674(04)00045-5.
  • Chen Z, Lin J, Wu S, Xu C, Chen F, Huang Z. Up-regulated miR-548k promotes esophageal squamous cell carcinoma progression via targeting long noncoding RNA-LET. Exp Cell Res. 2018;362:90–101. doi:10.1016/j.yexcr.2017.11.006.
  • Deng J, Deng H, Liu C, Liang Y, Wang S. Long non-coding RNA OIP5-AS1 functions as an oncogene in lung adenocarcinoma through targeting miR-448/Bcl-2. Biomed Pharmacother. 2018;98:102–110. doi:10.1016/j.biopha.2017.12.031.
  • Wei G, Xu Y, Peng T, Yan J. miR-133 involves in lung adenocarcinoma cell metastasis by targeting FLOT2. Artif Cells Nanomed Biotechnol. 2018;46:224–230. doi:10.1080/21691401.2017.1324467.
  • Wan YL, Dai HJ, Liu W, Ma HT. miR-767-3p inhibits growth and migration of lung adenocarcinoma cells by regulating CLDN18. Oncol Res. 2018;26:637–644. doi:10.3727/096504017X15112639918174.
  • Jia B, Xia L, Cao F. The role of miR-766-5p in cell migration and invasion in colorectal cancer. Exp Ther Med. 2018;15:2569–2574. doi:10.3892/etm.2018.5716.
  • Cai B, Zheng Y, Ma S, Xing Q, Wang X, Yang B, Yin G, Guan F. BANCR contributes to the growth and invasion of melanoma by functioning as a competing endogenous RNA to upregulate Notch2 expression by sponging miR204. Int J Oncol. 2017;51:1941–1951. doi:10.3892/ijo.2017.4173.
  • Wang K, Jin W, Song Y, Fei X. LncRNA RP11-436H11.5, functioning as a competitive endogenous RNA, upregulates BCL-W expression by sponging miR-335-5p and promotes proliferation and invasion in renal cell carcinoma. Mol Cancer. 2017;16:166. doi:10.1186/s12943-017-0735-3.
  • Huang X, Liu C, Hao C, Tang Q, Liu R, Lin S, Zhang L, Yan W. Identification of altered microRNAs and mRNAs in the cumulus cells of PCOS patients: miRNA-509-3p promotes oestradiol secretion by targeting MAP3K8. Reproduction. 2016;151:643–655. doi:10.1530/REP-16-0071.
  • Hu Y, Qiu Y, Yague E, Ji W, Liu J, Zhang J. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer. Cell Death Dis. 2016;7:e2291. doi:10.1038/cddis.2016.194.
  • Chen B, Ma J, Li C, Wang Y. Long noncoding RNA KCNQ1OT1 promotes proliferation and epithelialmesenchymal transition by regulation of SMAD4 expression in lens epithelial cells. Mol Med Rep. 2018;18:16–24. doi:10.3892/mmr.2018.8987.
  • Wang Y, Lu Z, Wang N, Feng J, Zhang J, Luan L, Zhao W, Zeng X. Long noncoding RNA DANCR promotes colorectal cancer proliferation and metastasis via miR-577 sponging. Exp Mol Med. 2018;50:57. doi:10.1038/s12276-018-0082-5.
  • Zhou J, Shi J, Fu X, Mao B, Wang W, Li W, Li G, Zhou S. Linc00441 interacts with DNMT1 to regulate RB1 gene methylation and expression in gastric cancer. Oncotarget. 2018;9:37471–37479. doi:10.18632/oncotarget.v9i101.
  • Gu LP, Jin S, Xu RC, Zhang J, Geng YC, Shao XY, Qin LB. Long non-coding RNA PCAT-1 promotes tumor progression by inhibiting miR-129-5p in human ovarian cancer. Arch Medl Sci. 2019;15:513–521. doi:10.5114/aoms.2018.75534.
  • Wu N, Han Y, Liu H, Jiang M, Chu Y, Cao J, Lin J, Liu Y, Xu B, Xie X, et al. miR-5590-3p inhibited tumor growth in gastric cancer by targeting DDX5/AKT/m-TOR pathway. Biochem Biophys Res Commun. 2018;503:1491–1497. doi:10.1016/j.bbrc.2018.07.068.
  • Zhang Y, Li J, Jia S, Wang Y, Kang Y, Zhang W. Down-regulation of lncRNA-ATB inhibits epithelial-mesenchymal transition of breast cancer cells by increasing miR-141-3p expression. Biochem Cell Biol. 2019;97:193–200. doi:10.1139/bcb-2018-0168.
  • Zhao B, Zhang J, Chen X, Xu H, Huang B. Mir-26b inhibits growth and resistance to paclitaxel chemotherapy by silencing the CDC6 gene in gastric cancer. Arch Medl Sci. 2019;15:498–503. doi:10.5114/aoms.2018.73315.
  • Xu H, Jiang J, Zhang J, Cheng L, Pan S, Li Y. MicroRNA-375 inhibits esophageal squamous cell carcinoma proliferation through direct targeting of SP1. Exp Ther Med. 2019;17:1509–1516. doi:10.3892/etm.2018.7106.
  • Wu LK, Liu YC, Ma G, Shi LL, He XM. High levels of glucose promote the activation of hepatic stellate cells via the p38-mitogen-activated protein kinase signal pathway. Genetics Mol Res. 2016;15. DOI:10.4238/gmr.15038419.
  • Jung YC, Han S, Hua L, Ahn YH, Cho H, Lee CJ, Lee H, Cho -Y-Y, Ryu J-H, Jeon R, et al. Kazinol-E is a specific inhibitor of ERK that suppresses the enrichment of a breast cancer stem-like cell population. Biochem Biophys Res Commun. 2016;470:294–299. doi:10.1016/j.bbrc.2016.01.066.
  • Wang H, Ke J, Guo Q, Barnabo Nampoukime KP, Yang P, Ma K. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis. J Cell Mol Med. 2018;22:5862–5876. doi:10.1111/jcmm.13856.
  • Xu M, Zhou K, Wu Y, Wang L, Lu S. Linc00161 regulated the drug resistance of ovarian cancer by sponging microRNA-128 and modulating MAPK1. Mol Carcinog. 2019;58:577–587. doi:10.1002/mc.v58.4.
  • Diao L, Wang S, Sun Z. Long noncoding RNA GAPLINC promotes gastric cancer cell proliferation by acting as a molecular sponge of miR-378 to modulate MAPK1 expression. Onco Targets Ther. 2018;11:2797–2804. doi:10.2147/OTT.S165147.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.